All Fields
Computer Science
Medicine
FAQ
Contact
Sign in
Phosphate Binder [EPC]
Known as:
Phosphate Binder
Â
Â
National Institutes of Health
Topic mentions per year
Topic mentions per year
2005-2017
0
2
4
6
2005
2017
Related topics
Related topics
1 relation
Phosphate Binders
Related mentions per year
Related mentions per year
2005-2018
2000
2005
2010
2015
2020
Phosphate Binder [EPC]
Phosphate Binders
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis: Phase 3 Randomized Trial.
Tadao Akizawa
,
Hideki Origasa
,
Chisato Kameoka
,
Junko Tsukada
,
Kentarou Kuroishi
,
Yusuke Yamaguchi
Therapeutic apheresis and dialysis : official…
2016
Currently, calcium- or metal-containing phosphate binders are available to treat hyperphosphatemia in predialysis patients with…Â
(More)
Is this relevant?
2015
2015
Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.
Kausik Umanath
,
Diana I. Jalal
,
+14 authors
J. P. O ’ Dwyer
Journal of the American Society of Nephrology…
2015
Ferric citrate (FC) is a phosphate binder with shown efficacy and additional effects on iron stores and use of intravenous (iv…Â
(More)
Is this relevant?
2015
2015
The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
Peter Noel Van Buren
,
Julia B. Lewis
,
+13 authors
Daniel E Weiner
American journal of kidney diseases : the…
2015
BACKGROUND Phosphate binders are the cornerstone of hyperphosphatemia management in dialysis patients. Ferric citrate is an iron…Â
(More)
Is this relevant?
2015
2015
Feasibility study of colestipol as an oral phosphate binder in hemodialysis patients.
Christopher John Hood
,
Martin J. Wolley
,
Angela L Kam
,
Jamie C Kendrik-Jones
,
Mark Roger Marshall
Nephrology
2015
BACKGROUND Currently available calcium- and aluminium-based phosphate binders are dose limited because of potential toxicity, and…Â
(More)
Is this relevant?
2014
2014
A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis.
Keitaro Yokoyama
,
Takashi Akiba
,
+5 authors
Hideki Hirakata
Nephrology, dialysis, transplantation : official…
2014
BACKGROUND JTT-751 is a novel phosphate binder containing ferric citrate as the active ingredient. METHODS In this Phase 3…Â
(More)
Is this relevant?
2014
2014
Reduction of costs for anemia-management drugs associated with the use of ferric citrate
Anila M Thomas
,
Leif E. Peterson
International journal of nephrology and…
2014
BACKGROUND Ferric citrate is a novel phosphate binder which has the potential to reduce usage of erythropoietin-stimulating…Â
(More)
Is this relevant?
2014
2014
Cost-minimization analysis of lanthanum carbonate versus sevelamer hydrochloride in US patients with end-stage renal disease.
Michael S Keith
,
Rosamund J. Wilson
,
Peter Preston
,
J Brian Copley
Clinical therapeutics
2014
PURPOSE Sevelamer hydrochloride (SH) and lanthanum carbonate (LC) are calcium-free phosphate binders used in the clinical…Â
(More)
Is this relevant?
2014
2014
The utility of the phosphate binder, ferric citrate hydrate (JTT-751), about phosphorus absorption-reducing effect in normal rats.
Akira Matsuo
,
Akio Iida
,
Minako Tanimoto
,
Mutsuyoshi Matsushita
,
K. Miyamoto
Renal failure
2014
Hyperphosphatemia is a risk factor for arterial calcification contributing to the high-cardiovascular mortality in patients with…Â
(More)
Is this relevant?
2014
2014
Real-world dose-relativity, tablet burden, and cost comparison of conversion between sevelamer hydrochloride/carbonate and lanthanum carbonate monotherapies.
Michael S Keith
,
Scott P. Sibbel
,
J Brian Copley
,
Rosamund J. Wilson
,
Steven M. Brunelli
Clinical therapeutics
2014
PURPOSE Sevelamer hydrochloride/carbonate (SH/C) and lanthanum carbonate (LC) are noncalcium-based phosphate binders used for the…Â
(More)
Is this relevant?
2013
2013
A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study
Adrian A Covic
,
Jutta Passlick-Deetjen
,
+5 authors
Angel L. M. de Francisco
Nephrology, dialysis, transplantation : official…
2013
BACKGROUND Different phosphate binders exert differing effects on bone mineral metabolism and levels of regulating hormones. The…Â
(More)
Is this relevant?